In breast cancer cell lines, Kim and colleagues showed that this compound reduces SIRT1 enzymatic activity and protein levels, increases p51 acetylation, reduces nuclear levels of SIRT1 and discloses nonepigenetic effects, specifically, cell growth inhibition and cell cycle arrest at G2/M phase [62]. The gene discussed is SIRT1; the disease is breast carcinoma.